Appearance

Active: dark

Light warmth: 0%0 = neutral light, 100 = warm sepia light.Dark depth: 0%0 = neutral dark, 100 = midnight black.

Accent

Custom

Corner radius

Font

Layout

Sidebar width: 224pxChat width: 50%

Data refresh

Auto-ingest on app launchAuto-ingest source

Runs once per app session in the background and keeps existing data if source APIs are unavailable.

Annotation style

HighlightStrike

User/group key (shared note namespace)

Ask · OpenAI

Refine NL queries with model

Requires OPENAI_API_KEY on the server. Heuristics always run first.

← Disease database

neutral lipid storage disease

Neutral lipid storage disease (NLSD) refers to a group of diseases characterized by a deficit in the degradation of cytoplasmic triglycerides and their accumulation in cytoplasmic lipid vacuoles in most tissues of the body. The group is heterogeneous: currently cases of NLSD with icthyosis (NLSDI/Dorfman-Chanarin disease) and NLSD with myopathy (NLSDM/neutral lipid storage myopathy) can be distinguished.

Therapeutic area: Endocrine / Metabolic
Rarity: Unknown
Prevalence: —
MONDO: MONDO:0015611

Overview

Neutral lipid storage disease (NLSD) refers to a group of diseases characterized by a deficit in the degradation of cytoplasmic triglycerides and their accumulation in cytoplasmic lipid vacuoles in most tissues of the body. The group is heterogeneous: currently cases of NLSD with icthyosis (NLSDI/Dorfman-Chanarin disease) and NLSD with myopathy (NLSDM/neutral lipid storage myopathy) can be distinguished.

Content last reviewed: 2026-06